Transient increase in CSF GAP-43 concentration after ischemic stroke

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2377
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Transient increase in CSF GAP-43 concentration after ischemic stroke ; volume:18 ; number:1 ; day:7 ; month:12 ; year:2018 ; pages:1-8 ; date:12.2018
BMC neurology ; 18, Heft 1 (7.12.2018), 1-8, 12.2018

Creator
Sandelius, Åsa
Cullen, Nicholas C.
Källén, Åsa
Rosengren, Lars
Jensen, Crister
Kostanjevecki, Vesna
Vandijck, Manu
Zetterberg, Henrik
Blennow, Kaj
Contributor
SpringerLink (Online service)

DOI
10.1186/s12883-018-1210-5
URN
urn:nbn:de:101:1-2019012621073644111254
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Sandelius, Åsa
  • Cullen, Nicholas C.
  • Källén, Åsa
  • Rosengren, Lars
  • Jensen, Crister
  • Kostanjevecki, Vesna
  • Vandijck, Manu
  • Zetterberg, Henrik
  • Blennow, Kaj
  • SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Repeated lumbar punctures within 3 days may affect CSF biomarker levels

Repeated lumbar punctures within 3 days may affect CSF biomarker levels

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

Related objects